Pharmacovigilance Studies Of Commonly Encountered Adverse Drug Reactions Reported From M.K.C.G. Medical College& Hospital, Berhampur
Keywords:
Adverse drug reactions, Cutaneous adverse drug reactions, Pharmacovigilance, cancer chemotherapeutic agents, Psychotropic drugsAbstract
Background: The relevance of Pharmacovigilance to adverse drug reaction(ADR) detection is highlighted worldwide. Pharmacovigilance starting from the tip of clinical trial in industries up to post -marketing surveillance is essential to ensure the drug safety. As newer drugs are entering market at a rapid pace pharmacovigilance with special attention to monitor and report adverse drug reaction is today’s need.
Objective: This study on adverse drug reaction monitoring and reporting was carried out in collaboration the departments of dermatology, psychiatry, pediatrics, radiotherapy of MKCG Medical College, Berhampur. Data obtained from this study may throw some light in the network of pharmacovigilance and bring a change in the safety data profile of established as well as upcoming drugs
Methods: This was a prospective, observational study, carried from January 2013 to October 2014 in collaboration with department of dermatology, psychiatry, paediatric and radiotherapy of MKCG Medical College and hospital (tertiary care hospital). Incidence rate for occurrence of adr were calculated using MS office excel 2010. Column statistics expressing mean, standard deviation, median, range, confidence interval, for different parameters of ADRs were calculated using a statistical software, Graphpad prism version 5.0.
Results: Out of 237 ADR cases 90 were cutaneous ADRs. Among the various patterns of Cutaneous adverse drug reactions (CADRs), the major presentations were exfoliative dermatitis (n= 17; 18.89%), Fixed drug eruption (n= 17;78%) and 15.56% of them were urticarial rashes. Drugs suspected to cause CADR in the study population were broadly classified in 10 groups. Among them 26.67% of CADR were caused by various NSAIDs. In this study, a total of 9900 patients attending psychiatry OPD were screened for ADR. Out of which 60 patients were suspected at least one ADR (0.61%). Seven major different kinds of psychotropic drugs were used for different kind of psychiatry illness. Extrapyramidal side effects was the commonest ADR (n=41; 34.17%) reported followed by weight gain (n=35; 29.17%). Anticholinergic side effects and sedation were observed in 16.17% and 10.83% of cases respectively. In this study period total 57 paediatric patients reported with different ADRs. Among them 61.40% patients were male and 38.60% were female. The commonest drug to develop ADR was ofloxacin (26.28%) followed by diclofenac (14.04%). Only 12.28% of ADR were with Ceftriaxone and metronidazole. During this study period a total 326 patients received different cancer chemotherapeutic agents among which 30 patients (9.22%) developed various ADRs. The most common ADR was nausea and vomiting (53.33%), hematological ADR (40%), hepatotoxicity skin rash and diarrohea were least to occur.
Conclusion: The patterns of the adverse drug reactions and the drugs which caused them, varied in our study according to the different pattern of the drug intake, the associated illness and the susceptibility of the patients. This study was able to recognize the ADRs within a short period and was limited to a solitary institute. Yet, the results convincingly prepare for the edifice to lead us to further long term active surveillance in early detection of ADRs and drug safety. Further study in collecting ADRS with drugs used in special situations, population and drug interactions is an immense need.
Downloads
Metrics
References
Dr.RohanC.Hire, Dr.ParagJkinage, Dr.Nilesh N.Gaikwad. Causality assessment in pharmacovigilance: a step towards quality care. Scholars Journal of Applied Medical Sciences2013;1(5):386-392
Saha Abanti, Das Nilay Kanti, Hazra Avijit, Gharami Ramesh Chandra, Chowdhury Satyendra Nath,Datta Pijush Kanti.Cutaneous adverse drug profile in a tertiary care outpatient setting in eastern india.indian j pharmacol 2012;44(6):792-7
Gairik Sengupta, Subhrojyoti Bhowmick, Avijit hazra,Ananya Datta,Musfikur Rahaman. ADR monitoring of psychotropoic drugs in an Indian hospital.indian journal of pharmacology 2011;43:36-39.
Ravi Philip Raj kumar,George melvin.Pharmacovigilance to psychiatry: an introduction.indian j psychiatry 2014.56;(2):176-181.
R. Priyadharsini, A. Surendiran, C. Adithan, S. Sreenivasan1, Firoj Kumar Sahoo.. Adverse drug reactions in paediatric population. Journal of Pharmacology and Pharmacotherapeutics 2011;2(4):277-80
Anju Prasad, Pratyay Pratim Datta1, Jibak Bhattacharya, Chaitali Pattanayak, Ashok Singh Chauhan1 and Parbaty Panda. Journal of Pharmacovigilance 2013; 1(2).1000107.
www.who-umc.org
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32
Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reactions: A one year survey at a dermatology outpatient clinic of a tertiary care hospital. Indian J Pharmacol 2006;38:429-31
Ghosh S, Acharya LD, Rao PG. Study and evaluation of various cutaneous adverse drug reaction in Kasturaba Hospital, Manipal. Indian J Pharm Sci 2006;68: 212-5
Patel RM, Marfatia Y S. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430
Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions:Clinical pattern and causative agents - a 6 year series from Chandigarh, India.J Postgrad Med 2001;47:95-
Smyth, R.M., Gargon, E., Kirkham, J., Cresswell, L., Golder, S., Smyth, R., Williamson, P. Adverse drug reactions in children-a systematic review. PLoS ONE 3 2012, e24061
.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.